Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Monolithic Power Systems | MPWR | Oct 11, 2024 | 938.47 | +0.90 |
Monopar Therapeutics | MNPR | Oct 11, 2024 | 5.50 | +6.38 |
Monro | MNRO | Oct 11, 2024 | 26.91 | +0.75 |
Monroe Capital | MRCC | Oct 11, 2024 | 8.08 | 0.00 |
Monster Beverage | MNST | Oct 11, 2024 | 51.31 | +1.06 |
Montana Technologies A | AIRJ | Oct 11, 2024 | 5.76 | -2.21 |
Montauk Renewables | MNTK | Oct 11, 2024 | 5.75 | +2.31 |
Monte Rosa Therapeutics | GLUE | Oct 11, 2024 | 4.93 | +1.86 |
Montrose Environmental Group | MEG | Oct 11, 2024 | 22.33 | +9.73 |
Moodys | MCO | Oct 11, 2024 | 475.11 | +1.22 |
Moog A | MOG-A | Oct 11, 2024 | 201.20 | +3.25 |
Moog B | MOG-B | Oct 11, 2024 | 198.87 | 0.00 |
Moolec Science | MLEC | Oct 11, 2024 | 0.90 | +8.41 |
MoonLake Immunotherapeutics | MLTX | Oct 11, 2024 | 48.94 | +4.13 |
Morgan Stanley | MS | Oct 11, 2024 | 110.46 | +2.20 |
Morgan Stanley China A Share Fund | CAF | Oct 11, 2024 | 13.59 | -0.07 |
Morgan Stanley Direct Lending Fund | MSDL | Oct 11, 2024 | 20.09 | -0.20 |
Morgan Stanley Emerging Markets Debt Fund | MSD | Oct 11, 2024 | 7.79 | -0.38 |
Morgan Stanley Emerging Markets Domestic Debt Fund | EDD | Oct 11, 2024 | 4.95 | +0.41 |
Morgan Stanley FXDFR Pref | MS-K | Oct 11, 2024 | 25.60 | +0.51 |
Morgan Stanley India Investment Fund | IIF | Oct 11, 2024 | 28.76 | -0.10 |
Morgan Stanley Pref A | MS-A | Oct 11, 2024 | 22.87 | +0.53 |
Morgan Stanley Pref E | MS-E | Oct 11, 2024 | 25.30 | +0.16 |
Morgan Stanley Pref F | MS-F | Oct 11, 2024 | 25.28 | +0.12 |
Morgan Stanley Pref I | MS-I | Oct 11, 2024 | 25.49 | +0.20 |
Morgan Stanley Pref L | MS-L | Oct 11, 2024 | 23.93 | +1.40 |
Morgan Stanley Pref O | MS-O | Oct 11, 2024 | 20.61 | +1.23 |
Morgan Stanley Pref P | MS-P | Oct 11, 2024 | 26.56 | +0.91 |
Morgan Stanley Pref Q | MS-Q | Oct 11, 2024 | 26.83 | 0.00 |
Morningstar | MORN | Oct 11, 2024 | 340.08 | +1.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.